While marijuana cultivation is legal at the state level in 33 American states, it remains federally illegal, making it impossible for U.S. companies to have their securities listed on any U.S. stock exchange. That being the case, many U.S. based companies in the cannabis business (referred to as multi-state operators or MSOs) have embraced the recent opportunity to list their stocks on the NEO stock exchange to take advantage of full capital markets support. This article highlights 2 ETFs that provide exposure to this burgeoning market and the rationale for investing in them.
2. Cannabis Central: Don't Buy A Marijuana ETF Until You've Read This Article!
Should investors invest in one of the marijuana ETFs? Before doing so one needs to do their homework and this article, unlike any other article you have read on the subject, does just that. This article identifies all the marijuana ETFs currently available and outlines the many differences between them with answers to the following questions:
OTC Markets Group's OTCQX Cannabis Index tracks 30 marijuana stocks providing an ideal way to track the pulse of the market.
Purpose Marijuana Opportunities Fund ETF (NEO:MJJ) is Canada's first actively managed cannabis fund, designed to help investors grow their portfolios by tapping into the burgeoning global cannabis industry.
The knock on stocks in the marijuana sector is their high volatility but here are some marijuana stocks (non-bio/pharma) with betas less than 2.
US-based cannabis sales are projected to reach US$75 billion in 2030 which will outpace the US$60B in wine sales of the $60 billion and almost match the US$77B in cigarette sales. This explosion in the cannabis market has caught the attention of big name brands hailing from other markets who can benefit from the integration of cannabis-based business. This article identifies 9 major consumer and pharmaceutical corporations who have bought into marijuana companies to take full advantage of this rapidly growing market.
The cannabis market has continued to be a highlight for numerous catalysts as companies announce acquisitions, financings, and partnerships and this article provides a recap of corporate activities in the cannabis industry over the past month:
Given all the interest in "pot" stocks and ETFs these days one would think that the cannabis sector was setting the world on fire but the truth of the matter is that the performance of almost 100% of the 135+ "pot" stocks & ETFs out there that I follow are way down this month - way down - except this 1 stock. This article identifies that stock and provides a solid reason why that is the case.
Investors should take a close look at all relevant data points before making any decisions, especially in a higher-risk environment such as the emerging marijuana industry. Choosing lower-risk stocks which allow for some indirect exposure to the industry, such as the ones above, could be an opportune move for investors, especially for those that desire dividend income from their stock holdings.
These 8 stocks, by the fact that they are listed on major stock exchanges in both Canada and the U.S., are well placed to attract major institutional attention and the potential for major price appreciation as more investors get on board. It might serve new investors well to seriously consider these stocks instead of venturing into the much more volatile juniors in the space.
Canopy Growth announced its Q1 financial results yesterday & the market did not take kindly to what it reported as the stock dropped almost 20% today.
Trulieve Cannabis Corp. (CSE:TRUL; OTCQX:TCNNF) announced its financial results for the second quarter of 2019 ended June 30, 2019 this past Wednesday after the markets closed. Financial Highlights (All the financial information provided below is reported in U.S. dollars, unless otherwise indicated and all comparable figures are for the previous (Q1) quarter unless otherwise indicated.) Revenue increased by 250% on a ?